Market Place
Sourcing Support
Debiopharm, Aspen Partner To Launch Prostate Cancer Drug Trelstar In S. Africa
01 Feb 2022 //
PRNEWSWIRE
Ipsen poaches Novartis vet Mari Scheiffele
11 Oct 2021 //
FIERCEPHARMA
Arbor Pharmaceuticals, LLC Confirms Availability of Triptodur® (triptorelin)
25 Aug 2020 //
PRNEWSWIRE
Arbor Pharmaceuticals, LLC Confirms Availability of Triptodur® (triptorelin)
25 Aug 2020 //
PRNEWSWIRE
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Nov 2019 //
FIERCE BIOTECH
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Oct 2019 //
FIERCE BIOTECH
Myovant`s oral prostate cancer drug matches incumbent in phase 3
20 Oct 2019 //
FIERCE BIOTECH
Arbor & Debiopharm International Announce Commercial Availability of Triptodur
03 Oct 2017 //
PR NEWSWIRE
Arbor & Debiopharm Announce U.S. FDA Approval for Triptodur™, Triptorelin 6-month Formulation
01 Jul 2017 //
PR NEWSWIRE
Debiopharm’s triptorelin 6-month formulation receives EU approval
20 Mar 2017 //
EU PHARMACEUTICAL
Debiopharm, EORTC Announce a Collaboration to Investigate Triptorelin
13 Jan 2016 //
PR NEWS WIRE
Debiopharm,Arbor Announce Their US Commercialization Partnership for Triptorelin
11 Jan 2016 //
PR NEWS WIRE
Unilab market Debiopharm`s prostate cancer drug,Pamorelin LA in Philippines
07 Dec 2015 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.